Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)

Program contacts by research area:

Moria Bittmann, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
301.451.7699
moria.bittmann@nih.gov

Deborah E. Linares, PhD, MA
National Institute on Minority Health and Health Disparities (NIMHD)
301.451.2516
deborah.linares@nih.gov

Peer review contact:
Manana Sukhareva, PhD
301.451.3397
sukharem@mail.nih.gov

Financial and grants management contacts by research area:

Monique Binger, PhD
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
301.451.4787
monique.day@nih.gov

Priscilla Grant, JD
National Institute on Minority Health and Health Disparities
301.594.8412
pg38h@nih.gov

The Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) program provides funding to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. Priority health disparity populations include racial and ethnic minorities, socioeconomically disadvantaged individuals, sexual and gender minorities, and medically underserved populations in rural and urban areas.

Applications should address one or more barriers in developing technologies that will impact health disparities. Examples include:

• Physical: Such as proximity to healthcare facilities and transportation
• Knowledge: Such as health literacy, language barriers, and lack of patient information for the healthcare provider
• Infrastructure: Resources, expertise, and medical technologies in rural hospitals and community health centers
• Economic: Internet access, insurance coverage, and financial resources
• Cultural: Religious beliefs and social customs that deter certain populations from seeking healthcare

Medical technologies may include, but are not limited to:

• Telehealth and telemedicine technologies for remote diagnosis and monitoring
• Sensors for point-of-care diagnosis
• Devices for in-home monitoring
• Mobile, portable diagnostic and therapeutic systems
• Devices which integrate diagnosis and treatment
• Diagnostics or treatments that do not require special training
• Devices that can operate in low-resource environments
• Non-invasive technologies for diagnosis and treatment
• Integrated, automated systems to assess or monitor specific conditions
• Robotic devices for performing specialized skills or enhancing usability
• Low cost biomaterial interfaces to increase medical device and component affordability

Eligible applicants include:

• Higher education institutions
  • Public/state controlled institutions
  • Private institutions
• Nonprofit organizations
  • With 501(c)(3) status
  • Without 501(c)(3) status
  • Native American tribal organizations
  • Faith-based or community-based organizations
  • Regional organizations
• Governments
  • State
  • County
  • City or township
  • Special districts
  • Federally recognized Indian/Native American tribal governments
  • Indian/Native American tribal governments (other than federally recognized)
  • Eligible agencies of the federal government
  • U.S. territory or possession
• Other
  • Independent school districts
  • Public housing authorities
  • Indian housing authorities
  • Small businesses
  • For-profit organizations

Projects must involve a formal collaboration with at least one public health agency, healthcare organization, tribal health organization, and/or community-based organization or group that supports health promotion and disease prevention programs and activities in underserved or disadvantaged communities, outside of clinical settings or healthcare systems.

Award ceiling: $500,000 per year
Project period: 4 years
Estimated number of awards: 3-4
Estimated total program funding: $2,400,000

Links to the full announcement, application instructions, and the online application process are available through grants.gov.

All AIDS and AIDS-related applications are due by May 2, 2024.

Note: This opportunity is listed under a single Funding Opportunity Announcement Number, RFA-EB-21-001, and 2 different Catalog of Federal Domestic Assistance (CFDA) Numbers based on research area.

• 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health
• 93.307 - Minority Health and Health Disparities Research

This opportunity expires on May 3, 2024.